文献速递自身免疫性与大疱性皮肤病

大疱性类天疱疮全球发病率:系统综述与荟萃分析

The global incidence of bullous pemphigoid: a systematic review and meta-analysis.
PubMed 文献 · Br J Dermatol · 2021-11-30

BACKGROUND: Bullous pemphigoid (BP) is an autoimmune blistering disorder that mainly affects older people. Although the disease is associated with considerable morbidity and mortality, the burden of disease worldwide is unclear.…

核心结论

  • BP全球发病率总体较低但随时间呈上升趋势,疾病负担可能被低估。

研究设计与样本

  • 采用Joanna Briggs Institute工具独立评估研究质量,以随机效应模型合并累积发病率并标准化为1年。

主要发现

  • 仅纳入成人的研究(n=2)、基于人群的研究(n=9)及近年研究发病率更高。
  • 所有合并估计均存在高异质性(I2>82%)。

临床怎么用

  • 临床需认识BP全球发病率虽低但呈上升趋势,尤其在老年人群中应保持警惕。
  • 欧洲与亚洲发病率差异提示地区性流行病学特征,可参考本地数据优化资源配置。

局限性

  • 合并估计存在高异质性(I2>82%)。
  • 仅少数研究提供发病率,部分亚组样本量小(如仅成人研究n=2)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bullous pemphigoid (BP) is an autoimmune blistering disorder that mainly affects older people. Although the disease is associated with considerable morbidity and mortality, the burden of disease worldwide is unclear. OBJECTIVES: The study aim is to pool the global incidence of BP and determine whether this varies according to geographic area, age group, setting and study quality. METHODS: Ovid MEDLINE, Ovid Embase and grey literature were systematically searched on 7 April 2020. Two reviewers independently screened, extracted data and appraised each study's quality using the Joanna Briggs Institute critical appraisal tool. Two domains, indicative of selection and survey bias, were used to identify high-quality studies. The cumulative incidence was standardized to 1 year and pooled in a random-effects meta-analysis. Subgroup and sensitivity analyses were conducted. RESULTS: Twenty-seven studies were identified, of which 23 provided cumulative incidence and four provided incidence rates. The cumulative incidence of BP was 8·2 [95% confidence interval (CI) 4·8-13.7] per million people whereas the incidence rate was 34·2 (95% CI 19·2-60·7) per million person-years. Of the continents that contributed more than one study, the cumulative incidence was 10·3 (95% CI 5·8-18·2) and 5·6 (95% CI 3·5-9·0) per million people in Europe and Asia, respectively. The incidence was highest in studies including adults only (n = 2), in population-based studies (n = 9) and in more recent years. The cumulative incidence was higher (13·3 per million people, 95% CI 6·0-29·5) when restricting the analysis to higher-quality studies (n = 11). High heterogeneity (I2 > 82%) was observed across all pooled estimates. CONCLUSIONS: The incidence of BP varies globally, is generally low but appears to be increasing over time. The burden of disease is likely to be underestimated.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Persson MSM, Begum N, Grainge MJ, et al. The global incidence of bullous pemphigoid: a systematic review and meta-analysis. Br J Dermatol. 2021. PMID: 34480482. doi:10.1111/bjd.20743

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。